Advocate Illinois Masonic Medical Center

Patient Safety - Central Line Associated Bloodstream Infections (CLABSIs)

Central Line Associated Bloodstream Infections (CLABSIs)

Presented below are annual central line-associated bloodstream infections (CLABSIs) occurring in critical care units, also known as intensive care units (ICUs). ICU-specific summary data for CLABSI are provided using the Standardized Infection Ratio(SIR). Statewide summaries of CLABSI data arranged by ICU type and hospital are also included.

Export

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
38	Exempt: No Licensed PICU Beds
42	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
44	Complete Reporting: Too few central line days to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
169	Exempt: No Licensed ICU Beds

Adult CLABSI

Pediatric CLABSI

Ped. CLABSI Measure	Result	SIR
Pediatric Medical-Surgical ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection (CLABSI) data in the Medical-Surgical Pediatric ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2015 - Q4 2015 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2014 - Q4 2014 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2012 - Q4 2012 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2011 - Q4 2011 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q4 2010 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q2 2010 Result N/A infections, N/A central-line days ³⁸ Rating SIR: 0.00 ³⁸	N/A infections, N/A central-line days ³⁸	0.00 ³⁸

NICU CLABSI

Illinois Hospital Report Card

and Consumer Guide to Health Care

Advocate Illinois Masonic Medical Center

Patient Safety - Central Line Associated Bloodstream Infections (CLABSIs)

Central Line Associated Bloodstream Infections (CLABSIs)

Statistical Significance

Footnotes

Adult CLABSI

Description

Historical Data

Description

Historical Data

Pediatric CLABSI

Description

Historical Data

NICU CLABSI

Description

Historical Data

Description

Historical Data

Adult CLABSI Measure	Result	SIR
Adult Surgical ICU Q1 2023 - Q4 2023 Result 2 infections, 1171 central-line days Rating SIR: 1.51	2 infections, 1171 central-line days	1.51
Description Central Line-associated Bloodstream Infection data in the Adult Surgical ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 0 infections, 1364 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1364 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2021 - Q4 2021 Result 2 infections, 1370 central-line days Rating SIR: 1.29	2 infections, 1370 central-line days	1.29
Q1 2020 - Q4 2020 Result 1 infections, 1526 central-line days Rating SIR: 0.58	1 infections, 1526 central-line days	0.58
Q1 2019 - Q4 2019 Result 0 infections, 1146 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1146 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2018 - Q4 2018 Result 0 infections, 1065 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1065 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2017 - Q4 2017 Result 0 infections, 1144 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1144 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2016 - Q4 2016 Result 0 infections, 1001 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1001 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2015 - Q4 2015 Result 2 infections, 1104 central-line days Rating SIR: 0.79	2 infections, 1104 central-line days	0.79
Q1 2014 - Q4 2014 Result 0 infections, 1163 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1163 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2013 - Q4 2013 Result 1 infections, 1010 central-line days Rating SIR: 0.43	1 infections, 1010 central-line days	0.43
Q1 2012 - Q4 2012 Result 1 infections, 1306 central-line days Rating SIR: 0.33	1 infections, 1306 central-line days	0.33
Q1 2011 - Q4 2011 Result 3 infections, 1282 central-line days Rating SIR: 1.02	3 infections, 1282 central-line days	1.02
Q1 2010 - Q4 2010 Result 3 infections, 1902 central-line days Rating SIR: 0.69	3 infections, 1902 central-line days	0.69
Q1 2009 - Q4 2009 Result 4 infections, 2430 central-line days Rating SIR: 0.72	4 infections, 2430 central-line days	0.72
Q1 2009 - Q2 2009 Result 1 infections, 1206 central-line days Rating SIR: 0.83	1 infections, 1206 central-line days	0.83
Adult Medical ICU Q1 2023 - Q4 2023 Result 2 infections, 1124 central-line days Rating SIR: 1.58	2 infections, 1124 central-line days	1.58
Description Central Line-associated Bloodstream Infection data in the Adult Medical ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 1 infections, 1285 central-line days Rating SIR: 0.69	1 infections, 1285 central-line days	0.69
Q1 2021 - Q4 2021 Result 6 infections, 1630 central-line days Rating SIR: 3.26	6 infections, 1630 central-line days	3.26
Q1 2020 - Q4 2020 Result 3 infections, 1556 central-line days Rating SIR: 1.71	3 infections, 1556 central-line days	1.71
Q1 2019 - Q4 2019 Result 0 infections, 1008 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1008 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2018 - Q4 2018 Result 2 infections, 737 central-line days ⁴⁴ Rating SIR: N/A ⁴⁴	2 infections, 737 central-line days ⁴⁴	N/A ⁴⁴
Q1 2017 - Q4 2017 Result 0 infections, 872 central-line days ⁴² Rating SIR: N/A ⁴²	0 infections, 872 central-line days ⁴²	N/A ⁴²
Q1 2016 - Q4 2016 Result 1 infections, 681 central-line days ⁴⁴ Rating SIR: N/A ⁴⁴	1 infections, 681 central-line days ⁴⁴	N/A ⁴⁴
Q1 2015 - Q4 2015 Result 0 infections, 731 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 731 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2014 - Q4 2014 Result 0 infections, 744 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 744 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2013 - Q4 2013 Result 0 infections, 789 central-line days ⁴⁶ Rating SIR: 0.00 ⁴⁶	0 infections, 789 central-line days ⁴⁶	0.00 ⁴⁶
Q1 2012 - Q4 2012 Result 2 infections, 1177 central-line days Rating SIR: 0.65	2 infections, 1177 central-line days	0.65
Q1 2011 - Q4 2011 Result 1 infections, 1474 central-line days Rating SIR: 0.26	1 infections, 1474 central-line days	0.26
Q1 2010 - Q4 2010 Result 1 infections, 1789 central-line days Rating SIR: 0.22	1 infections, 1789 central-line days	0.22
Q1 2009 - Q4 2009 Result 3 infections, 1860 central-line days Rating SIR: 0.62	3 infections, 1860 central-line days	0.62
Q1 2009 - Q2 2009 Result 1 infections, 1054 central-line days Rating SIR: 0.95	1 infections, 1054 central-line days	0.95

NICU CLABSI Measure	Result	SIR
Level II/III Neonatal ICU Q1 2016 - Q4 2016 Result 1 infections, 1505 central-line days Rating SIR: 0.41	1 infections, 1505 central-line days	0.41
Description Central Line-associated Bloodstream Infection data in the Level II/III Neonatal ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2015 - Q4 2015 Result 3 infections, 1168 central-line days Rating SIR: 1.10	3 infections, 1168 central-line days	1.10
Q1 2014 - Q4 2014 Result 3 infections, 1578 central-line days Rating SIR: 0.72	3 infections, 1578 central-line days	0.72
Q1 2013 - Q4 2013 Result 4 infections, 2796 central-line days Rating SIR: 0.49	4 infections, 2796 central-line days	0.49
Q1 2012 - Q4 2012 Result 2 infections, 1767 central-line days Rating SIR: 0.40	2 infections, 1767 central-line days	0.40
Q1 2011 - Q4 2011 Result 3 infections, 1837 central-line days Rating SIR: 0.61	3 infections, 1837 central-line days	0.61
Q1 2010 - Q4 2010 Result 3 infections, 1838 central-line days Rating SIR: 0.61	3 infections, 1838 central-line days	0.61
Q1 2010 - Q2 2010 Result 3 infections, 534 central-line days Rating SIR: 1.85	3 infections, 534 central-line days	1.85
Level III Neonatal ICU Q1 2023 - Q4 2023 Result 1 infections, 367 central-line days Rating SIR: N/A	1 infections, 367 central-line days	N/A
Description Central Line-associated Bloodstream Infection data in the Level III Neonatal ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 0 infections, 167 central-line days ⁴² Rating SIR: N/A ⁴²	0 infections, 167 central-line days ⁴²	N/A ⁴²
Q1 2021 - Q4 2021 Result 0 infections, 313 central-line days ⁴² Rating SIR: N/A ⁴²	0 infections, 313 central-line days ⁴²	N/A ⁴²
Q1 2020 - Q4 2020 Result 1 infections, 416 central-line days ⁴⁴ Rating SIR: N/A ⁴⁴	1 infections, 416 central-line days ⁴⁴	N/A ⁴⁴
Q1 2019 - Q4 2019 Result 0 infections, 884 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 884 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2018 - Q4 2018 Result 0 infections, 770 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 770 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2017 - Q4 2017 Result 0 infections, 1034 central-line days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 1034 central-line days ¹¹⁷	0.00 ¹¹⁷
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days Rating SIR: N/A	N/A infections, N/A central-line days	N/A